You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRAD001

Showing 1 - 25 of 224
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Growth and Development Trial in Belgium, Russian Federation, United States (Everolimus, Envirolimus drug class as prescribed by

Active, not recruiting
  • Growth and Development
  • Everolimus
  • Envirolimus drug class as prescribed by Physician
  • Los Angeles, California
  • +5 more
Dec 5, 2022

Advanced Hormone Receptor Positive (HR+) Breast Cancer Trial (everolimus)

No longer available
  • Advanced Hormone Receptor Positive (HR+) Breast Cancer
  • (no location specified)
Nov 26, 2021

Head Neck Cancer Trial in Providence (RAD001(Afinitor))

Terminated
Has Results
  • Head and Neck Cancer
  • Providence, Rhode Island
    Rhode Island Hospital
Feb 13, 2020

Uterine Cancer Trial in Baltimore (Letrozole, Everolimus)

Completed
  • Uterine Cancer
  • Baltimore, Maryland
    Greater Baltimore Medical Center
Feb 4, 2020

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following

Active, not recruiting
  • HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
  • Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
  • Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
  • Calgary, Alberta, Canada
  • +24 more
Sep 12, 2022

Renal Angiomyolipoma Trial (Everolimus)

Not yet recruiting
  • Renal Angiomyolipoma
  • (no location specified)
Aug 15, 2022

Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)

Completed
  • Advanced Breast Cancer
  • Guangzhou, Guangdong, China
  • +14 more
Jun 17, 2022

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • San Francisco, California
  • +7 more
Aug 5, 2022

Stomatitis, Oral Mucositis, Tumor of the Breast Trial in US (Miracle Mouthwash Plus Hydrocortisone, Prednisolone)

Completed
  • Stomatitis
  • +3 more
  • US, Texas
    12 sites incl Yakima, WA, Boulder, CO, and Austin, TX
Nov 29, 2022

Pancreatic Neuroendocrine Tumors Trial in Beijing, Shanghai, Guangzhou (everolimus)

Active, not recruiting
  • Pancreatic Neuroendocrine Tumors
  • Beijing, Beijing, China
  • +3 more
Sep 27, 2021

Advanced or Metastatic Pancreatic Adenocarcinoma Trial in Germany (everolimus)

Completed
  • Advanced or Metastatic Pancreatic Adenocarcinoma
  • Halle, Germany
  • +4 more
Dec 17, 2020

Metastatic Renal Cell Carcinoma Trial in China (Everolimus (RAD001))

Completed
  • Metastatic Renal Cell Carcinoma
  • Everolimus (RAD001)
  • Wuhan, Hubei, China
  • +6 more
Dec 17, 2020

Non-Hodgkin's Lymphoma Trial in Japan (Everolmus)

Completed
  • Non-Hodgkin's Lymphoma
  • Nagoya-city, Aichi, Japan
  • +7 more
Dec 17, 2020

Breast Tumors, Tumor Metastasis Trial in Worldwide (everolimus (RAD001))

Completed
  • Breast Neoplasms
  • Neoplasm Metastasis
  • everolimus (RAD001)
  • Bruxelles, Belgium
  • +5 more
Dec 17, 2020

Hepatic Insufficiency Trial in Frankfurt, Moscow, Singapore (Everolimus)

Completed
  • Hepatic Insufficiency
  • Frankfurt, Germany
  • +2 more
Dec 17, 2020

Small-Cell Lung Cancer Trial in France, United States (Everolimus)

Completed
  • Small-Cell Lung Cancer
  • Fayetteville, Arkansas
  • +5 more
Dec 17, 2020

Non Small Cell Lung Cancer Trial in Australia, Belgium, Germany (Everolimus, Pemetrexed)

Completed
  • Non Small Cell Lung Cancer
  • Camperdown, New South Wales, Australia
  • +4 more
Dec 17, 2020

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

Non Small Cell Lung Cancer Trial in Worldwide (RAD001, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Atlanta, Georgia
  • +13 more
Dec 17, 2020

Breast Cancer, Triple Negative Breast Cancer Trial in Houston, Sugar Land (Everolimus)

Completed
Has Results
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Houston, Texas
  • +2 more
Jul 16, 2021

Alterations in Cognitive Function and Cerebral Blood Flow After

Recruiting
  • End Stage Renal Disease
  • Kansas City, Kansas
    University of Kansas Medical Center
Mar 1, 2021

Advanced Solid Tumors, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma Trial in Worldwide (RAD001 + BEZ235)

Completed
  • Advanced Solid Tumors
  • +2 more
  • RAD001 + BEZ235
  • Fayetteville, Arkansas
  • +9 more
Dec 17, 2020

Acute Ischemic Stroke Trial in China (Injection of recombinant human tissue plasminogen kinase derivatives, Recombinant human

Recruiting
  • Acute Ischemic Stroke
  • Injection of recombinant human tissue plasminogen kinase derivatives
  • Recombinant human tissue plasminogen activator
  • Bengbu, Anhui, China
  • +77 more
Oct 14, 2022

Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of

Recruiting
  • Lung Cancer
  • +2 more
    • Palo Alto, California
      VA Palo Alto Health Care System
    Oct 6, 2022

    Progressive Gastrointestinal Stromal Tumor Trial in Germany (Imatinib mesylate)

    Completed
    • Progressive Gastrointestinal Stromal Tumor
    • Imatinib mesylate
    • Berlin, Germany
    • +6 more
    Sep 8, 2020